EMAMILTDNSEQ2 FY2024September 30, 2023

Emami Limited

4,594words
41turns
0analyst exchanges
6executives
Management on call
Percy Panthaki
IIFL SECURITIES LIMITED
Mohan Goenka
WHOLE TIME DIRECTOR &
Vivek Dhir
CHIEF EXECUTIVE OFFICER,
Gulraj Bhatia
PRESIDENT HEALTHCARE– EMAMI LIMITED
Manish Gupta
PRESIDENT SALES – EMAMI LIMITED
Rajesh Sharma
PRESIDENT FINANCE & INVESTOR RELATIONS
Key numbers — 37 extracted
865 Crore
ond quarter and first half ending 30th September 2023. In Q2, our consolidated revenues soared to 865 Crores demonstrating 6% growth. Our domestic business exhibited fairly impressive resilience with a 4% g
6%
lf ending 30th September 2023. In Q2, our consolidated revenues soared to 865 Crores demonstrating 6% growth. Our domestic business exhibited fairly impressive resilience with a 4% growth in net sales
4%
rores demonstrating 6% growth. Our domestic business exhibited fairly impressive resilience with a 4% growth in net sales and a nearly 2% increase in volumes. Notably urban centric channels like moder
2%
omestic business exhibited fairly impressive resilience with a 4% growth in net sales and a nearly 2% increase in volumes. Notably urban centric channels like modern trade and e-commerce witnessed ro
12%
t dynamics. On a brand level, Navratna and Dermi Cool range performed well and recorded growth of 12% in Q2. While healthcare range grew by 4% and pain management by 1%. Boroplus male grooming and Kes
1%
ed well and recorded growth of 12% in Q2. While healthcare range grew by 4% and pain management by 1%. Boroplus male grooming and Kesh King range declined in single digits on account of lower consume
63%
tments in subsidiaries Helios and Brillare Sciences outperformed expectations witnessing a stellar 63% growth. Internationally, we continued our upward trajectory growing by an impressive 16% in consta
16%
a stellar 63% growth. Internationally, we continued our upward trajectory growing by an impressive 16% in constant currency and 12% in INR terms. Despite challenges in certain markets due to currency
350 basis point
wer input costs and judicious price hikes, we achieved a significant expansion of gross margins by 350 basis points reaching 70.1%. Our EBITDA registered robust growth climbing by 20% to 234 Crores with margin ex
70.1%
us price hikes, we achieved a significant expansion of gross margins by 350 basis points reaching 70.1%. Our EBITDA registered robust growth climbing by 20% to 234 Crores with margin expanding to 27%, a
20%
gross margins by 350 basis points reaching 70.1%. Our EBITDA registered robust growth climbing by 20% to 234 Crores with margin expanding to 27%, a rise of 300 basis points. For the first half of the
234 Crore
margins by 350 basis points reaching 70.1%. Our EBITDA registered robust growth climbing by 20% to 234 Crores with margin expanding to 27%, a rise of 300 basis points. For the first half of the financial ye
Advertisement
Guidance — 15 items
Abneesh Roy
opening
On the overall company for the India business, if you could tell e-commerce and modern trade, what is the growth and do you expect acceleration given festival demand will be in Q3, would you expect that?
Abneesh Roy
opening
So we expect to have similar kinds of growth coming from both the channels, both from modern trade and e-com.
Mohan Goenka
opening
At the same time with our project Khoj reaching out to almost 60,000 villages.
S hirish Pardeshi
opening
So when do we see a double-digit growth and the part two to this question is that do you think the second half also we will be seeing a very strong double-digit growth in the international business?
Manish Gupta
opening
Shirish CIS Russia this is one bad quarter which happened for us due to some uncontrollable issues but when you look at the CAGR over the quarters and quarters, it is performing very well for us that market and we expect it to bounce back in Q3 and Q4 again to a decent growth rates due to the efforts which we had made in the marketplace over the years.
Manish Gupta
opening
So we see a very bright future in this market going forward as well.
Manish Gupta
opening
I mean the base is now going to be normalized in second half also so can we expect a double-digit growth?
Manish Gupta
opening
M ay not be strong double-digit growth, but definitely high single digit growth is what we are seeing and we do see the market being on an upward trend and the general business will be on upper trend in the coming quarters.
Manish Gupta
opening
Okay my last question on the sales front, I think M ohan ji you alluded saying that project Khoj, the project is now done.
Manish Gupta
opening
So I think project Khoj has prepared the foundation and laid the very solid foundation for reach to these markets.
Risks & concerns — 10 flagged
Unfortunately, as I said, the markets are slightly weak.
Mohan Goenka
We are well geared, but very difficult to say when the market would bounce back.
Mohan Goenka
I would say yes, the markets are still weak and most of the growth in this quarter has come from the e-com and some of our strategic investments that we had done.
Mohan Goenka
Second half margins, again Shirish I am saying that is not a concern honestly because raw material prices are still benign.
Mohan Goenka
As I said both these channels, modern t rade and e- com, which now contributes to almost 24-25% there the margins are relatively lower compared to the GT channels and we see significant improvement in margins in some of these channels, so margin is not a concern.
Mohan Goenka
On the portfolio of the male grooming, the Fair and Handsome, what really we need to do to make this brand sort of back on the growth path because I understand the overall demand scenario is weak and as that improves of course that is one part of the equation.
Percy Panthaki
The concern which happened was more internal in nature and we could not handle that particular thing and that is behind us now on that particular issue.
Manish Gupta
So actually on the back of Zandu better Q1, w e did see a decline in terms of the growth numbers in Q2 specifically in the medico business.
Manish Gupta
If you see the overall market for various reasons in Q2 for the entire OTC and medico business is a bit of a challenge more stagnant in Q2.
Manish Gupta
We can recover very significantly if the winter sets in well and there is good amount of rural recovery but in this difficult times I would say 7% is also a good top line number.
Mohan Goenka
Advertisement
Speaking time
Mohan Goenka
13
S hirish Pardeshi
7
Moderator
6
Abneesh Roy
4
Nitin
4
Percy Panthaki
2
Manish Gupta
2
Gulraj Bhatia
1
Prakash Kapadia
1
Rajesh S harma
1
Opening remarks
Mohan Goenka
Emami Limited November 06, 2023 Ladies and gentlemen, good day and welcome to Q2 FY2024 Earnings Conference Call of Emami Limited hosted by IIFL Securities Limited. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing ‘*’ then ‘0’ on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to M r. Percy Panthaki from IIFL Securities Limited. Thank you and over to you! Hi good evening everyone. Thanks for joining us on the Emami results con call. I have with me M r. M ohan Goenka – Whole Time Director and Vice Chairman; M r. Vivek Dhir – CEO, International Business; M r. Gulraj Bhatia, President, Healthcare, M r. M anish Gupta – President Sales and M r. Rajesh Sharma – President Finance and IR. I will hand over the call M r. M ohan Goenka who
Gulraj Bhatia
Emami Limited November 06, 2023 positive indicators that bolsters our confident in the recovery of rural markets. Our unwavering focus remains on driving our long-term strategic goals and enhancing our capabilities. We are determined to continue investing in our brands ensuring superior value for our consumers. With these efforts and the resilience that is a hallmark of Emami's journey, we are confident in our ability to deliver consistent, responsible and profitable growth in the medium to long term. With this overview, I invite Q&A. Thank you. We will now begin the question-and-answer session. We have the first question from the line of Abneesh Roy from Nuvama Institutional Equities. Please go ahead. Thanks and congrats on the margins. M y first question is on the D2C Zanducare business. So essentially I see a lot of new products being launched. So my question is out of the Zandu portfolio what percentage of the products which are sold on Zandu D2C website are also available on third
Abneesh Roy
On the overall company for the India business, if you could tell e-commerce and modern trade, what is the growth and do you expect acceleration given festival demand will be in Q3, would you expect that?
Mohan Goenka
So the growth has been in the range of about 17 to 18% in modern trade and for e- commerce it is about 50% growth in this quarter.
Abneesh Roy
So we expect to have similar kinds of growth coming from both the channels, both from modern trade and e-com. In fact, our e-com has now reached to almost 13% of our total business and modern trade is at 11%. So put together, we have almost reached to 24% both M T and e-com. One last follow up I remember at the end of FY2023 now you had said e-commerce plus modern day is 20% of business. So this year you want to do more focus on profitability rather than sales growth. I see sales growth being strong could you address on profitability, is it meeting your initial… Emami Limited November 06, 2023
Mohan Goenka
Yes Abneesh so that is part of our overall margin expansion plan because now both the channels put together is around 25% of our total business and margins are slightly lower compared to our GT business. Definitely we have improved our margins in both the channels. There is further scope of improving margins in e-com in modern trade. It will come gradual but yes, there are levers of margin expansions in these two channels.
Advertisement
← All transcriptsEMAMILTD stock page →